Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ORIFARM GROUP A/S - Group

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   0.4% 0.5% 0.5% 0.8% 0.8% 0.7% 5.2% 5.1%   Credit score (0-100)   99 99 98 90 92 92 43 43   Credit rating   AAA AAA AA AA AA AA BBB BBB   Credit limit (mEUR)   17.8 21.8 18.7 18.7 22.4 26.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mEUR)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   833 982 1,115 1,417 1,513 1,568 1,568 1,568   Gross profit   131 151 120 184 231 268 0.0 0.0   EBITDA   48.0 58.9 52.5 92.1 104 125 0.0 0.0   EBIT   38.1 47.4 39.9 55.5 58.8 76.0 0.0 0.0   Pre-tax profit (PTP)   34.9 45.4 37.2 37.5 33.8 30.0 0.0 0.0   Net earnings   26.5 34.7 25.5 28.7 25.7 22.4 0.0 0.0   Pre-tax profit without non-rec. items   34.9 45.4 37.2 37.5 33.8 30.0 0.0 0.0     See the entire income statement 1.0 Balance sheet (mEUR)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   25.7 28.7 41.2 110 123 136 0.0 0.0   Shareholders equity total   136 168 149 170 187 208 205 205   Interest-bearing liabilities   132 151 219 630 680 689 0.0 0.0   Balance sheet total (assets)   344 424 494 1,120 1,183 1,230 205 205   Net Debt   132 151 219 627 670 687 -124 -124     See the entire balance sheet 1.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   833 982 1,115 1,417 1,513 1,568 1,568 1,568   Net sales growth   4.5% 17.8% 13.6% 27.0% 6.8% 3.6% 0.0% 0.0%   Gross profit   131 151 120 184 231 268 0.0 0.0   Gross profit growth   8.9% 15.0% -20.1% 52.5% 25.6% 16.3% -100.0% 0.0%   Employees   1,036 1,111 1,177 1,955 2,136 2,244 0 0   Employee growth %   5.8% 7.2% 5.9% 66.1% 9.3% 5.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   344 424 494 1,120 1,183 1,230 205 205   Balance sheet change%   -4.5% 23.1% 16.6% 126.8% 5.6% 4.0% -83.3% 0.0%   Added value   48.0 58.9 52.5 92.1 95.3 125.1 0.0 0.0   Added value %   5.8% 6.0% 4.7% 6.5% 6.3% 8.0% 0.0% 0.0%   Investments   -2 5 6 69 -35 -38 -161 0   Net sales trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   5.8% 6.0% 4.7% 6.5% 6.8% 8.0% 0.0% 0.0%   EBIT %   4.6% 4.8% 3.6% 3.9% 3.9% 4.8% 0.0% 0.0%   EBIT to gross profit (%)   29.1% 31.5% 33.1% 30.3% 25.5% 28.3% 0.0% 0.0%   Net Earnings %   3.2% 3.5% 2.3% 2.0% 1.7% 1.4% 0.0% 0.0%   Profit before depreciation and extraordinary items %   4.4% 4.7% 3.4% 4.6% 4.7% 4.6% 0.0% 0.0%   Pre tax profit less extraordinaries %   4.2% 4.6% 3.3% 2.6% 2.2% 1.9% 0.0% 0.0%   ROA %   11.9% 13.7% 10.1% 7.8% 5.1% 6.9% 0.0% 0.0%   ROI %   15.4% 17.6% 13.2% 10.1% 6.6% 8.9% 0.0% 0.0%   ROE %   20.9% 22.9% 16.1% 18.0% 14.4% 11.4% 0.0% 0.0%   1.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   39.5% 39.6% 30.2% 15.1% 15.8% 16.9% 100.0% 100.0%   Relative indebtedness %   24.3% 25.4% 30.1% 62.3% 61.9% 62.4% 0.0% 0.0%   Relative net indebtedness %   24.3% 25.4% 30.1% 62.1% 61.3% 62.2% -7.9% -7.9%   Net int. bear. debt to EBITDA, %   274.3% 255.5% 418.4% 680.9% 647.3% 549.0% 0.0% 0.0%   Gearing %   96.8% 89.7% 147.3% 371.4% 363.2% 331.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.9% 5.2% 4.9% 6.0% 3.8% 7.7% 0.0% 0.0%   1.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 0.5 0.5 0.8 0.8 0.8 0.0 0.0   Current Ratio   1.4 1.4 1.2 1.8 1.8 1.8 0.0 0.0   Cash and cash equivalent   0.0 0.1 0.0 2.8 9.8 2.3 0.0 0.0   1.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   44.5 42.1 44.1 49.9 51.0 49.4 0.0 0.0   Trade creditors turnover (days)   316.5 439.1 319.5 445.5 259.4 272.3 0.0 0.0   Current assets / Net sales %   29.8% 31.6% 32.5% 33.0% 35.0% 37.5% 7.9% 7.9%   Net working capital   75.0 88.9 63.4 213.8 240.5 262.5 0.0 0.0   Net working capital %   9.0% 9.1% 5.7% 15.1% 15.9% 16.7% 0.0% 0.0%   1.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   1 1 1 1 1 1 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0